18 June 2013
Keywords: hivid, approved, uk, hoffmann-la, roche, received, approval
Article | 19 September 1994
- Hoffmann-La Roche has received approval in the UK for its antiviral Hivid (zalcitabine) as a monotherapy treatment for adult patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.